Hypertension and Diabetes Melitus Type II Associated with Systemic Corticosteroids: Challenges of Pemphigus Vulgaris Therapy in the Elderly

Authors

  • Nanda Earlia Departement of Dermatology and Venereology, Faculty of Medicine Syiah Kuala University, Banda Aceh, Aceh, Indonesia/dr. Zainoel Abidin General Hospital, Banda Aceh, Aceh, Indonesia
  • Aldilla Pradistha Faculty of Medicine Syiah Kuala University, Banda Aceh, Aceh, Indonesia
  • Mikyal Bulqiah Faculty of Medicine Syiah Kuala University, Banda Aceh, Aceh, Indonesia
  • Abid Dhiyauddin Alfani Irsyah Faculty of Medicine Syiah Kuala University, Banda Aceh, Aceh, Indonesia
  • Fadel Daman Faculty of Medicine Syiah Kuala University, Banda Aceh, Aceh, Indonesia
  • Tifani Assa Faculty of Medicine Syiah Kuala University, Banda Aceh, Aceh, Indonesia

Keywords:

Pemphigus vulgaris, diabetes mellitus, hypertension, corticosteroid, side effects.

Abstract

Long-term treatment and high doses of systemic corticosteroids in Pemphigus Vulgaris (PV) also carry the risk of various side effects, such as hypertension and diabetes mellitus. A male, 62 years old, has been diagnosed with PV accompanied by type 2 diabetes mellitus, and grade I hypertension. The patient was given therapy with dexamethasone 5 mg/day IV and mycophenolate mofetil 500 mg twice a day. Patients also receive treatment to control glucose and blood pressure, and debridement procedures are carried out. After administering therapy, the patient saw clinical improvement. Corticosteroid administration can also be combined with adjuvant steroid-sparing agents to increase the treatment effect, reduce the side effects of corticosteroids, and prevent recurrence if stopped gradually. The importance of considering side effects when administering corticosteroid therapy, and monitoring glucose and blood pressure can reduce morbidity and mortality in patients.

References

Payne AS, Stanley JR. Pemphigus Vulgaris. In: Kang S, editor. Fitzpatrick’s Dermatology. 9th ed. McGraw Hill; 2019. p. 909.

Drakel FF, Sufiawati I. A Rare Clinical Manifesta-tion of Pemphigus Vulgaris in Elderly Patient: A Case Report and Brief Review J Int Dent Med Res 2021; 14(3): 1144-48.

Susanto PM, Siahaan WMU. Pemphigus Vulgaris Management in Elderly Patient: A Case Report. S Med Jour. 2022;5(2):70.

Aviana F, Birawan IM. Efek Samping Steroid Sis-temik pada terapi Pemfigus Vulgaris. Cermin Dunia Kedokteran. 2021;330–4.

Zeng FAP, Wilson A, Sheriff T, Murrell DF. Side effects of steroid-sparing agents in patients with bullous pemphigoid and pemphigus: A systematic review JAAD Int. 2022;9:33-43.

Doi: 10.1016/j.jdin.2022.07.005. .

Shah P, Kalra S, Yadav Y, Deka N, Lathia T, Jacob JJ, et al. Management of Glucocorticoid-Induced Hyperglycemia. Diabetes Metab Syndr Obes. 2022;15:1577-1588.

Doi: 10.2147/DMSO.S330253.

Beaupere C, Liboz A, Fève B, Blondeau B, Guille-main G. Molecular mechanisms of glucocorticoid-induced insulin resistance. Int J Mol Sci. 2021 ;22(2):623. Doi: 10.3390/ijms22020623.

Sari DA, Samodra G, Kusuma IY. Molecular Mech-anism of Corticosteroid-Induced Hyperglycemia. Pharmacy Reports. 2021:79-82.

Pakirdinov AB, Muminov MM. Clinical Case of Difused form of Pemphigus Vulgaris in a Sick Fe-male at an Elderly Age I. Экономика и социум. 2022(12-2 (103):112-9.

Di Lernia V, Casanova DM, Goldust M, Ricci C. Pemphigus Vulgaris and Bullous Pemphigoid: Update on Diagnosis and Treatment. Dermatol Pract Concept. 2020;10(3):e2020050. Doi: 10.5826/dpc.1003a50.

Mebrahtu TF, Morgan AW, West RM, Stewart PM, Pujades-Rodriguez M. Oral glucocorticoids and in-cidence of hypertension in people with chronic in-flammatory diseases: a population-based cohort study. CMAJ. 2020;192(12):E295-E301. Doi: 10.1503/cmaj.191012.

Shah P, Kalra S, Yadav Y, Deka N, Lathia T, Jacob JJ, et al. Management of Glucocorticoid-Induced Hyperglycemia. Diabetes Metab Syndr Obes. 2022;15:1577 1588 `Doi:10.2147/DMSO.S330253.

Downloads

Published

2025-09-30

How to Cite

1.
Earlia N, Pradistha A, Bulqiah M, Irsyah ADA, Fadel Daman, Tifani Assa. Hypertension and Diabetes Melitus Type II Associated with Systemic Corticosteroids: Challenges of Pemphigus Vulgaris Therapy in the Elderly. J Pak Assoc Dermatol [Internet]. 2025Sep.30 [cited 2025Nov.25];35(3):268-71. Available from: https://jpad.com.pk/index.php/jpad/article/view/3021

Issue

Vol. 35 No. 3 (2025): July- September

Section

Case Reports

License

Copyright (c) 2025 Journal of Pakistan Association of Dermatologists

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Most read articles by the same author(s)